Molecular analysis of the interaction between HPV type 16 E6 and human E6‐associated protein
Open Access
- 13 October 1997
- journal article
- Published by Wiley in FEBS Letters
- Vol. 416 (1) , 6-10
- https://doi.org/10.1016/s0014-5793(97)01160-5
Abstract
The complex formed between the human papillomavirus type 16 E6 protein and human E6‐associated protein, which combine to ubiquitylate and degrade p53, has been studied by chemical crosslinking. Analysis of the interactions of proteins purified from Escherichia coli as well as proteins expressed in insect cells indicates that, while E6 has the capacity to form dimers, E6 and E6‐associated protein interact as two monomers to form a heterologous dimer.Keywords
This publication has 25 references indexed in Scilit:
- Protein ubiquitination involving an E1–E2–E3 enzyme ubiquitin thioester cascadeNature, 1995
- The ubiquitin-proteasome proteolytic pathwayCell, 1994
- E6-AP Directs the HPV E6-dependent Inactivation of p53 and Is Representative of a Family of Structurally and Functionally Related ProteinsCold Spring Harbor Symposia on Quantitative Biology, 1994
- The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53Cell, 1993
- Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53.Molecular and Cellular Biology, 1993
- THE UBIQUITIN-CONJUGATION SYSTEMAnnual Review of Genetics, 1992
- Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumoursThe Lancet, 1992
- The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53Published by Elsevier ,1990
- Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53Science, 1990
- A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions.Proceedings of the National Academy of Sciences, 1983